Actinic Keratosis
Clinical guidelines for managing precancerous skin lesions, field therapies, and cryosurgery.
Table of Contents
π§ Standard of Care & Risk
Actinic keratoses (AKs) are precancerous skin lesions caused by years of cumulative ultraviolet (UV) radiation exposure. They typically appear as dry, scaly, rough patches on chronically sun-exposed areas like the face, scalp, and back of the hands.
- Cancer Risk: While a single AK has a low chance of progressing to Squamous Cell Carcinoma (SCC) in a given year, a patient with multiple AKs has a cumulative risk that requires aggressive management to prevent skin cancer.
- Diagnosis: Usually diagnosed clinically by a dermatologist based on touch (they often feel like sandpaper) and appearance. Biopsy is only required if the lesion is very thick, tender, or rapidly growing (suggestive of SCC).
βοΈ Lesion-Directed Therapies
If a patient only has a few isolated AKs, treatment is directed specifically at those spots.
Cryosurgery (Liquid Nitrogen): The most common, rapid, and cost-effective treatment. The dermatologist sprays liquid nitrogen directly onto the lesion, freezing and destroying the abnormal cells. It stings and will cause a small blister that eventually peels off, leaving healthy skin.
π§΄ Field Therapies
When a patient has widespread AKs, treating just the visible spots is insufficient because the surrounding skin likely harbors microscopic, invisible precancers ("field cancerization").
- Topical 5-Fluorouracil (5-FU): A topical chemotherapy cream (e.g., Efudex) applied daily for 2 to 4 weeks. It selectively targets and destroys rapidly dividing, sun-damaged cells. It causes significant, highly visible redness, crusting, and discomfort during treatment, but yields excellent long-term clearance.
- Tirbanibulin Ointment: A newer, 5-day topical treatment that works by inhibiting cell division. It offers a shorter treatment course with generally milder localized skin reactions compared to 5-FU.
- Photodynamic Therapy (PDT): A photosensitizing liquid (ALA) is applied to the skin and allowed to incubate. The patient is then placed under a specific blue or red light source, which activates the liquid, destroying the precancerous cells.
π¬ Active Clinical Trials
Current research focuses on combining treatments to improve clearance rates and reduce the painful side effects of topical chemotherapies.
- NCT05221345 (National Cancer Institute): Evaluating the efficacy of combining low-dose 5-Fluorouracil with Calcipotriene to achieve robust clearance of AKs with a shorter, less painful treatment duration.
- NCT04899128 (Massachusetts General Hospital): A study optimizing the light dosimetry and incubation times for Daylight Photodynamic Therapy (Daylight PDT) to improve patient tolerability.
- NCT06187740 (Almirall): A Phase 4 study investigating the long-term recurrence rates of Actinic Keratosis following a 5-day course of Tirbanibulin 1% ointment.
πΊοΈ Next Steps After Diagnosis
A diagnosis of AKs is a clear warning sign from your skin. Act now to prevent progression to skin cancer:
- Commit to Field Therapy: If your dermatologist prescribes 5-FU, expect the skin to look and feel terrible for a few weeks (red, crusty, burning). Plan to do this treatment during the winter when sun exposure is lower and you are less socially active. Do not stop early.
- Establish a Baseline: Take well-lit photos of your face, scalp, and hands before starting any treatment. This helps you and your doctor track what actually cleared and what might need a biopsy later.
- Radical Sun Protection: It is not too late to prevent further damage. You must adopt a daily habit of broad-spectrum SPF 30+ (even on cloudy days) and wear wide-brimmed hats. Sunscreen can actually help existing AKs regress.
- Schedule Ongoing Checks: AKs are a chronic condition indicating severe UV damage. You need a professional, full-body skin exam every 6 to 12 months for the rest of your life.
β Patient FAQ
Q: If the spot peeled off after freezing, is it cured?
A: Usually, yes, that specific spot is cured. However, the surrounding skin has the same sun damage history, so new AKs frequently develop nearby over time. This is why annual skin checks are mandatory.
Q: Should I pick the scabs off during my 5-FU treatment?
A: Absolutely not. Picking increases the risk of bacterial infection and permanent scarring. Let the skin slough off naturally.
Get the Free 2026 Clinical AI Directory
Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.